Profil
Anders Sigvard Bjartell is the founder of Glactone Pharma AB, which was founded in 2012.
He is currently a Professor at the University of Lund and the Chief Urology Officer & Professor at Skane University Hospital.
He previously worked as a Director at LIDDS AB from 2015 to 2022.
Dr. Bjartell obtained a doctorate degree from the University of Lund.
Postes actifs de Anders Sigvard Bjartell
| Sociétés | Poste | Début |
|---|---|---|
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Develops inhibitors for the use in immuno-oncology and for the treatment of drug resistant cancers | Fondateur | 01/01/2012 |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Corporate Officer/Principal | - |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Anders Sigvard Bjartell
| Sociétés | Poste | Fin |
|---|---|---|
| LIDDS AB | Directeur/Membre du Conseil | 02/05/2022 |
Formation de Anders Sigvard Bjartell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Develops inhibitors for the use in immuno-oncology and for the treatment of drug resistant cancers | Health Technology |
















